Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-24 Sale |
2023-01-26 5:17 pm |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
85,317 | $6.0002 | $511,923 | 971,665 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:49 pm |
CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer |
100,000 | $6 | $600,000 | 479,565 (Direct) |
View |
| 2022-12-29 Sale |
2023-01-03 7:47 pm |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
115,583 | $6.0102 | $694,672 | 3,171,627 (Direct) |
View |
| 2022-12-29 Sale |
2023-01-03 6:36 pm |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
54,042 | $6.0058 | $324,564 | 1,493,032 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-14 4:42 pm |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
242,300 | $6.004 | $1,454,760 | 1,558,073 (Direct) |
View |
| 2022-11-08 Sale |
2022-11-10 4:54 pm |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
91,500 | $5.5849 | $511,019 | 63,000 (Direct) |
View |
| 2022-10-04 Sale |
2022-10-06 4:20 pm |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
2,109 | $6.2562 | $13,194 | 991,005 (Direct) |
View |
| 2022-09-29 Sale |
2022-10-03 6:26 pm |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
141,041 | $6.0466 | $852,825 | 1,603,063 (Direct) |
View |
| 2022-09-16 Sale |
2022-09-20 4:59 pm |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
22,592 | $6.02 | $136,004 | 484,321 (Direct) |
View |
| 2022-09-12 Sale |
2022-09-14 4:35 pm |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
242,300 | $6.43 | $1,557,989 | 941,115 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-16 4:07 pm |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
5,000 | $5.5 | $27,500 | 27,861 (Direct) |
View |
| 2022-08-09 Sale |
2022-08-11 5:52 pm |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner |
8,500,000 | $6.12 | $52,020,000 | 2,665,438 (Indirect Direct) |
View |
| 2022-07-07 Sale |
2022-07-11 4:51 pm |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
20,121 | $6.5104 | $130,995 | 0 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-07 5:02 pm |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
91,500 | $6.0772 | $556,067 | 48,621 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 5:19 pm |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
72,223 | $6.0278 | $435,343 | 3,552,969 (Direct) |
View |
| 2022-06-17 Sale |
2022-06-17 4:57 pm |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
60,000 | $6.2084 | $372,505 | 497,397 (Direct) |
View |
| 2022-06-14 Sale |
2022-06-16 4:19 pm |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
10,000 | $5.5 | $55,000 | 497,397 (Direct) |
View |
| 2022-06-01 Sale |
2022-06-03 6:16 pm |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
72,223 | $6.0025 | $433,520 | 3,763,455 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-26 Equity Swap |
2023-06-28 6:26 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner |
8,856,160 | $9.1 | 0 (Direct) |
View |
| 2023-06-26 Equity Swap |
2023-06-28 6:26 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner |
3,647 | $0 | 0 (Direct) |
View |
| 2023-06-26 Equity Swap |
2023-06-26 4:05 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | PERRY MATTHEW D Director |
43,139 | $9.1 | 0 (Direct) |
View |
| 2023-06-26 Equity Swap |
2023-06-26 4:05 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
48,639 | $9.1 | 0 (Direct) |
View |
| 2023-06-26 Equity Swap |
2023-06-26 4:05 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
17,547 | $9.1 | 0 (Direct) |
View |
| 2023-06-26 Equity Swap |
2023-06-26 4:05 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
31,470 | $9.1 | 0 (Direct) |
View |
| 2023-06-26 Equity Swap |
2023-06-26 4:05 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer |
3,565 | $9.1 | 0 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 6:25 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 6:22 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 6:20 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | Parks Diane L. Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 6:17 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 6:17 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 6:16 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | PERRY MATTHEW D Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 5:00 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner |
80,000 | $0 | 9,329,807 (Indirect) |
View |
| 2023-03-14 Option Award |
2023-03-16 5:52 pm |
N/A 2033-03-14 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
900,000 | $0 | 900,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 5:52 pm |
N/A 2033-03-14 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 5:52 pm |
N/A 2033-03-14 |
CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-12-16 Ownership |
2023-02-14 6:19 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
43,785 | $0 | 48,639 (Direct) |
View |
| 2023-01-24 Exercise |
2023-01-26 5:17 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
85,317 | $0 | 971,665 (Direct) |
View |
| 2023-01-24 Exercise |
2023-01-26 5:17 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
85,317 | $0.8411 | 971,665 (Direct) |
View |
| 2019-02-19 Option Award |
2023-01-26 4:49 pm |
N/A 2029-02-19 |
CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer |
288,000 | $0 | 479,565 (Direct) |
View |
| 2023-01-24 Exercise |
2023-01-26 4:49 pm |
N/A 2029-02-19 |
CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer |
100,000 | $0 | 479,565 (Direct) |
View |
| 2023-01-24 Exercise |
2023-01-26 4:49 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer |
100,000 | $0.9489 | 479,565 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 7:47 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
1,579 | $5.1085 | 3,171,627 (Direct) |
View |
| 2022-12-29 Exercise |
2023-01-03 7:47 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
115,583 | $0 | 3,171,627 (Direct) |
View |
| 2022-12-29 Exercise |
2023-01-03 7:47 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
115,583 | $0.8411 | 3,171,627 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 6:36 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
214 | $5.1085 | 1,493,032 (Direct) |
View |
| 2022-12-29 Exercise |
2023-01-03 6:36 pm |
N/A 2029-02-19 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
54,042 | $0 | 1,493,032 (Direct) |
View |
| 2022-12-29 Exercise |
2023-01-03 6:36 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
54,042 | $0.9489 | 1,493,032 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 4:42 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
242,300 | $0 | 1,558,073 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 4:42 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
242,300 | $0.8411 | 1,558,073 (Direct) |
View |
| 2022-11-08 Exercise |
2022-11-10 4:54 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
63,000 | $1 | 63,000 (Direct) |
View |
| 2022-11-08 Exercise |
2022-11-10 4:54 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
91,500 | $0 | 63,000 (Direct) |
View |
| 2022-11-08 Exercise |
2022-11-10 4:54 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
28,500 | $0.8411 | 63,000 (Direct) |
View |
| 2022-10-04 Exercise |
2022-10-06 4:20 pm |
N/A 2029-02-19 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
2,109 | $0 | 991,005 (Direct) |
View |
| 2022-10-04 Exercise |
2022-10-06 4:20 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
2,109 | $0.9489 | 991,005 (Direct) |
View |
| 2022-09-29 Exercise |
2022-10-03 6:26 pm |
N/A 2029-02-19 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
141,041 | $0 | 1,603,063 (Direct) |
View |
| 2022-09-29 Exercise |
2022-10-03 6:26 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
141,041 | $0.9489 | 1,603,063 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-20 4:59 pm |
N/A 2029-02-19 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
22,592 | $0 | 484,321 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-20 4:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
9,516 | $2.1165 | 484,321 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-20 4:59 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
22,592 | $0.9489 | 484,321 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 4:35 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
242,300 | $0 | 941,115 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 4:35 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
242,300 | $0.8411 | 941,115 (Direct) |
View |
| 2022-08-09 Conversion |
2022-08-11 5:52 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner |
8,395,906 | $0 | 2,665,438 (Direct) |
View |
| 2022-07-05 Exercise |
2022-07-07 5:02 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
91,500 | $0 | 48,621 (Direct) |
View |
| 2022-07-05 Exercise |
2022-07-07 5:02 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director |
91,500 | $0.8411 | 48,621 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-06 5:19 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
72,223 | $0 | 3,552,969 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-06 5:19 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
6,183 | $2.1165 | 3,552,969 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-06 5:19 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
72,223 | $0.8411 | 3,552,969 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-17 4:57 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
10,000 | $1 | 497,397 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-17 4:57 pm |
N/A 2030-03-11 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
60,000 | $0 | 497,397 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-17 4:57 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
50,000 | $3.3 | 497,397 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 4:19 pm |
N/A 2029-02-19 |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
10,000 | $0 | 497,397 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 4:19 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer |
10,000 | $0.9489 | 497,397 (Direct) |
View |
| 2022-06-01 Exercise(A) |
2022-06-03 7:15 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
72,223 | $0 | 3,746,777 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-03 6:16 pm |
N/A 2029-05-16 |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
72,223 | $0 | 3,763,455 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-03 6:16 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO |
72,223 | $0.8411 | 3,763,455 (Direct) |
View |